Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,716 signal articles · 245 in last 24h · 117,766 total before filter · latest 29m ago
245last 24h
1643last 7d
260● bullish (7d)
154● bearish (7d)
205publishers
AllMacro312Earnings700M&A92Regulatory27Product13Analyst23
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
IQM Quantum Computers Q2 Earnings Call Highlights
MarketBeat14d agoneutral
IQM Quantum Computers Q2 Earnings Call Highlights

IQM Quantum Computers (NASDAQ:IQMX) reported its first results as a public company, outlining a growing order backlog, a second-half-weighted revenue outlook and continued investment in superconducting quantum systems for high-performance computing environments. The company began trading on the Nas

IPG Photonics Q2 Earnings Call Highlights
MarketBeat14d agoneutral
IPG Photonics Q2 Earnings Call Highlights

IPG Photonics (NASDAQ:IPGP) reported second-quarter 2026 revenue of $279 million, up 11% from a year earlier and representing its third consecutive quarter of double-digit year-over-year sales growth. Revenue exceeded the midpoint of the company’s guidance, while bookings improved and book-to-bill r

Hut 8 Q2 Earnings Call Highlights
MarketBeat14d agoneutral
Hut 8 Q2 Earnings Call Highlights

Hut 8 (NASDAQ:HUT) reported second-quarter 2026 revenue growth and improved adjusted EBITDA as its compute operations expanded, while management highlighted progress on its AI data center development projects and project-level financing strategy. Revenue rose approximately 81% year over year to $74

Diamondback Energy Q2 Earnings Call Highlights
MarketBeat14d agoneutral
Diamondback Energy Q2 Earnings Call Highlights

Diamondback Energy (NASDAQ:FANG) said its second-quarter operational performance and view of global oil inventories support a potential path toward low-single-digit organic production growth in 2027, while management emphasized it intends to retain flexibility amid commodity-market volatility. Chie

Cipher Mining Q2 Earnings Call Highlights
MarketBeat14d agoneutral
Cipher Mining Q2 Earnings Call Highlights

Cipher Mining (NASDAQ:CIFR) said its second-quarter 2026 business update reflected continued progress in its transition toward developing and operating data centers for high-performance computing, or HPC, customers. The company highlighted an accelerated delivery at its Black Pearl campus, an $810 m

Bruker Q2 Earnings Call Highlights
MarketBeat14d agoneutral
Bruker Q2 Earnings Call Highlights

Bruker (NASDAQ:BRKR) reported second-quarter revenue growth and expanded profitability as demand improved for scientific instruments, particularly in biopharma and several “deep tech” markets including semiconductor metrology, security detection and energy research. Second-quarter reported revenue

Timken (TKR) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks14d agoneutral
Timken (TKR) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Timken (TKR) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Pfizer raises revenue outlook after quarterly earnings top estimates
Proactive14d agoneutral
Pfizer raises revenue outlook after quarterly earnings top estimates

Pfizer Inc (NYSE:PFE, XETRA:PFE) beat Wall Street expectations for its second-quarter 2026 results and raised the midpoint of its full-year revenue guidance, as growth from launched and acquired products helped offset declines in its COVID-19 portfolio. The pharmaceutical company reported...

BioNTech Q2 Earnings Call Highlights
MarketBeat14d agoneutral
BioNTech Q2 Earnings Call Highlights

BioNTech (NASDAQ:BNTX) reported second-quarter 2026 revenue of €106 million, down from €261 million a year earlier, as lower U.S. demand for its COVID-19 vaccine weighed on results. The prior-year quarter also benefited from a one-time compensation payment from Pfizer related to its decision to opt